Mimedx
MiMedx Group, Inc. is a biopharmaceutical company based in Marietta, Georgia, focused on developing and marketing regenerative biologics derived from human placental tissue allografts. Utilizing its proprietary PURION Process, the company employs aseptic processing techniques and terminal sterilization to create a range of allografts. Key products include EpiFix, a membrane designed for chronic wound treatment, and AmnioFix, which is used in surgical procedures. Other offerings consist of AmnioCord and EpiCord, dehydrated human umbilical cord allografts, and AmnioFill, a connective tissue matrix. MiMedx's products cater to various healthcare sectors, including wound care, burns, surgical applications, orthopedics, sports medicine, ophthalmics, and dentistry. The company distributes its products through a direct sales force, independent agents, and third-party representatives.
Top Stages
2 past transactions
Stability Biologics
Acquisition in 2016
Stability Biologics, LLC is a Nashville-based company that specializes in providing high-quality human tissue products to surgeons, hospitals, and surgical centers throughout the United States. The company develops a range of bioactive bone graft products and tissue allografts, including structural and particulate bone, demineralized bone matrix, and skin products for burn and wound care. By focusing on the surgical, spine, and orthopedic sectors, Stability Biologics supports healthcare professionals in performing safe and effective surgical procedures. Initially starting as a medical implant distributor, the company has expanded its operations to become a national provider of allograft solutions.
Surgical Biologics
Acquisition in 2010
Surgical Biologics specializes in the development and manufacturing of placental-based allografts, with a focus on minimally manipulated synthetic tissues. Based in Kennesaw, Georgia, the company has produced and distributed over 30,000 products designed for soft tissue repair procedures. Its advanced tissue processing techniques ensure the creation of safe and effective implants suitable for a variety of surgical applications, leveraging amnion membranes to meet diverse medical needs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.